{
  "main_header": {
    "sid": 1117609,
    "name": "Zhejiang Shapuaisi Pharmaceutical Co. Ltd.",
    "stock_name": "Zhejiang Shapuaisi Pharmaceutical Co. Ltd.",
    "full_name": "Zhejiang Shapuaisi Pharmaceutical Co. Ltd.",
    "name_url": "stocks-analysis/zhejiang-shapuaisi-pharmaceutical-co",
    "exchange": 47,
    "exchangecode": "SHG",
    "country_id": 12,
    "currency": "CNY",
    "cmp": "8.20",
    "chg": -0.1,
    "chgp": "-1.2%",
    "dir": -1,
    "prev_price": "8.30",
    "mcapval": "2,334.14",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "China Shanghai Composite",
    "isin": "CNE100001TG0",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "13.78 M",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zhejiang-shapuaisi-pharmaceutical-co-1117609-47&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Reports Strong Financial Performance in Q1 2025",
        "link": "https://www.marketsmojo.com/news/mojo-premium/zhejiang-shapuaisi-pharmaceutical-co-ltd-enters-hidden-turnarounds-strategy-due-to-strong-financial-performance-3526086",
        "imagepath": "",
        "date": "2025-09-17 17:14:47",
        "description": "<p><strong>Zhejiang Shapuaisi Pharmaceutical Co. Ltd.</strong>, a small-cap player in the Pharmaceuticals & Biotechnology sector, has reported impressive financial results for the quarter ending March 2025. The company has demonstrated significant growth, showcasing its potential for future profitability and resilience in the market.</p>\n\n<p>One of the key highlights of the financial performance is the substantial decrease in raw material costs, which fell by 24.65% year-over-year. This reduction has positively impacted the company's overall profitability, allowing it to achieve its highest pre-tax profit of CNY 14.03 MM for the quarter.</p>\n\n<p>In addition to the pre-tax profit, <strong>Zhejiang Shapuaisi Pharmaceutical Co. Ltd.</strong> recorded a net profit of CNY 11.83 MM, marking another peak in its financial journey. The earnings per share (EPS) also reached a high of CNY 0.02, reflecting the company'..."
      }
    ],
    "total": 1,
    "sid": "1117609",
    "stock_news_url": "https://www.marketsmojo.com/news/zhejiang-shapuaisi-pharmaceutical-co-1117609"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Zhejiang Shapuaisi Pharmaceutical Co. Ltd. Reports Strong Financial Performance in Q1 2025

2025-09-17 17:14:47

Zhejiang Shapuaisi Pharmaceutical Co. Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reported impressive financial results for the quarter ending March 2025. The company has demonstrated significant growth, showcasing its potential for future profitability and resilience in the market.

One of the key highlights of the financial performance is the substantial decrease in raw material costs, which fell by 24.65% year-over-year. This reduction has positively impacted the company's overall profitability, allowing it to achieve its highest pre-tax profit of CNY 14.03 MM for the quarter.

In addition to the pre-tax profit, Zhejiang Shapuaisi Pharmaceutical Co. Ltd. recorded a net profit of CNY 11.83 MM, marking another peak in its financial journey. The earnings per share (EPS) also reached a high of CNY 0.02, reflecting the company'...

Read More

View All News